We translate our deep biological insight into cell states to small-molecule therapeutics. Our approach provides novel ways of treating cancer, fibrosis, ischemia and immune modulation. Kojin Therapeutics is founded by Benjamin Cravatt, Stephanie Dougan, Stuart Schreiber and Vasanthi Viswanathan.